Essential Contribution of CD4+ T Cells to Antigen-Induced Nasal Hyperresponsiveness in Experimental Allergic Rhinitis
Overview
Authors
Affiliations
Nasal hyperresponsiveness (NHR) is a characteristic feature of allergic rhinitis (AR); however, the pathogenesis of NHR is not fully understood. In this study, during the establishment of an experimental AR model using ovalbumin-immunized and -challenged mice, augmentation of the sneezing reaction in response to nonspecific proteins as well as a chemical stimulant was detected. Whether NHR is independent of mast cells and eosinophils was determined by using mast cell- and eosinophil-deficient mice. NHR was suppressed by treatment with anti-CD4 antibody, suggesting the pivotal contribution of CD4+ T cells. Furthermore, antigen challenge to mice to which in vitro-differentiated Th1, Th2, and Th17 cells but not naïve CD4+ T cells had been adoptively transferred led to the development of equivalent NHR. Since antigen-specific IgE and IgG were not produced in these mice and since antigen-specific IgE-transgenic mice did not develop NHR even upon antigen challenge, humoral immunity would be dispensable for NHR. CD4+ T cells play a crucial role in the pathogenesis of AR via induction of NHR, independent of IgE-, mast cell-, and eosinophil-mediated responses.
Yamashita S, Miura K, Matsuura A, Yamasaki N, Uda N, Ogata S J Vet Med Sci. 2024; 86(7):824-827.
PMID: 38839347 PMC: 11251814. DOI: 10.1292/jvms.24-0033.
Modulating asthma-COPD overlap responses with IL-17 inhibition.
do Nascimento Camargo L, Righetti R, de Almeida F, Dos Santos T, Fukuzaki S, Martins N Front Immunol. 2023; 14:1271342.
PMID: 37965351 PMC: 10641519. DOI: 10.3389/fimmu.2023.1271342.
PLoS One. 2023; 18(1):e0279797.
PMID: 36630363 PMC: 9833536. DOI: 10.1371/journal.pone.0279797.
Suppressive Effect of subsp. YRC3780 on a Murine Model of Japanese Cedar Pollinosis.
Uchida K, Iida K, Fujioka I, Hachimura S, Kaminuma O Pathogens. 2022; 11(11).
PMID: 36422599 PMC: 9698324. DOI: 10.3390/pathogens11111347.
Th17-Dependent Nasal Hyperresponsiveness Is Mitigated by Steroid Treatment.
Ueda S, Miura K, Kawasaki H, Ogata S, Yamasaki N, Miura S Biomolecules. 2022; 12(5).
PMID: 35625602 PMC: 9138412. DOI: 10.3390/biom12050674.